Building Resilience Across the HI&I Value Chain

Between 2020 and 2023, household, industrial, and institutional (HI&I) supply chains were tested by overlapping demand, logistics, energy, and feedstock shocks. Resilience depends not only on procurement, but on the coordinated availability of surfactants, solvents, additives, actives, and packaging. A shortage in any formulation-critical input can delay shipment, force reformulation, or jeopardise regulatory and customer approval, turning disruption into a commercial, technical, and regulatory issue.

COVID-19 first fragmented demand. Household cleaning and hygiene demand surged, while hospitality, travel, education, offices, and food service demand contracted. Manufacturers scaled household supply while managing excess inventory and underutilised institutional capacity, weakening forecasts and making allocation decisions more consequential.

Pressure intensified in 2022 after Russia’s invasion of Ukraine. Brent crude averaged about $100 per barrel and Dutch TTF gas exceeded €300/MWh in late August. Higher energy and feedstock costs flowed into surfactants, solvents, and alcohols, while container shortages, port congestion, labour constraints, and packaging availability extended lead times. Plant outages, force majeure events, and regional capacity constraints further reduced flexibility.

Exposure varied by ingredient class. Surfactants and upstream feedstocks faced the greatest cost volatility because production depends on petrochemical intermediates, fatty alcohols, oleochemicals, and ethylene oxide. Solvents and alcohols were similarly exposed to energy and feedstock inflation.

By contrast, enzymes, chelates, preservatives, fragrance components, and performance polymers were less exposed to commodity prices but carried greater single-source, qualification, and supply concentration risk. Although a smaller share of formulation cost, their technical function, regulatory status, and limited supplier base can make substitution slow and costly. Commodity inputs faced price, allocation, and logistics disruption; specialty inputs faced concentration, long qualification cycles, and limited substitution options.

Regional exposure also differed. North America benefited from an integrated petrochemical and ethylene oxide value chain but remained exposed to feedstock volatility, plant outages, freight disruption, and global inflation. Europe faced a sharper combination of energy inflation, import dependence, and logistics disruption, particularly for surfactants, solvents, chelates, and other petrochemical-derived inputs. The energy shock materially increased the cost of ethylene oxide, alcohol ethoxylates, and related intermediates.

Asia presented a different profile. Malaysia and Indonesia are important sources of palm- and coconut-based oleochemicals, while China has substantial capacity in surfactant intermediates, quats, disinfectant actives, and plastic packaging. This scale creates cost advantages but also concentration risk. Production disruptions, port congestion, and logistics constraints quickly affected formulation, blending, and packaging across Southeast Asia and beyond. India has significant formulation and packing capacity but relies on imported oleochemical intermediates because domestic palm and coconut oil supply is insufficient. The result was a supply chain that was globally connected, regionally concentrated, and, in places, structurally import-dependent.

Disruption translated into higher costs, longer lead times, and allocation constraints. Rising raw material, energy, and logistics costs complicated planning, while suppliers prioritised strategic customers and key product lines. This has accelerated a shift toward sourcing decisions that balance cost, resilience, flexibility, and supplier risk.

Margin pressure was most acute where inflation could not be passed through. Consumer cleaning manufacturers balanced price recovery with affordability and competition, while industrial and institutional customers increasingly valued security of supply, technical support, and lowest total cost in use.

Supply availability became a key reformulation driver alongside cost, performance, and sustainability. When preferred ingredients became unavailable or uneconomical, formulators assessed alternatives that maintained cleaning performance, stability, safety, and compliance.

Substitution was rarely straightforward. Cleaning performance depends on ingredient interactions, so replacing one component often required wider formulation optimisation. Surfactant changes could affect foaming, detergency, rinsing, and compatibility with enzymes or bleach actives; preservative, fragrance, or solvent changes could affect shelf life, sensory properties, VOCs, and labelling. Companies with pre-screened substitutes and established validation processes maintained continuity more easily than competitors facing delayed qualification and customer approval.

Disruption accelerated a reassessment of supply chain strategy. Procurement has moved beyond cost-focused sourcing toward resilience, flexibility, and supplier-risk management. Manufacturers are adopting dual- or multi-sourcing, holding more critical inventory, and developing regional options where viable.

Supplier relationships have become more strategic. Better visibility of constraints, joint contingency planning, and closer collaboration across procurement, R&D, regulatory, and commercial functions improve responsiveness. Pre-screened substitutes and regulatory-ready reformulation pathways reduce response time.

Many vulnerabilities remain. Structural risks include concentrated specialty input production, long qualification lead times, and Asia’s role in key ingredient and packaging chains; energy volatility, freight disruption, and geopolitical uncertainty are cyclical but can recur sharply. Regulatory complexity further slows substitution, increasing the value of pre-qualified alternatives and cross-functional reformulation capability.

Resilience is not free, as dual sourcing, regionalisation, higher inventory, and pre-screened substitutes carry cost, working capital, and complexity penalties. The most effective companies will prioritise resilience where disruption would be most value-destroying.

For HI&I ingredient suppliers, formulators, brand owners, and investors, ChemQuest can help turn supply chain resilience into commercial advantage. When companies face disruption, margin pressure, reformulation challenges, or uncertainty over where their greatest exposure lies, we provide the market intelligence, technical insight, and strategic clarity needed to prioritise action.

Our team helps global clients to:

• Identify the ingredients, suppliers, regions, and customer relationships where disruption creates the greatest commercial risk
• Design sourcing and inventory strategies that balance cost with resilience
• Develop pre-qualified reformulation pathways
• Align procurement, R&D, regulatory, and commercial teams around a single resilience agenda

In HI&I, the competitive divide is between companies that treat resilience as a procurement cost and those that build it into sourcing, formulation, and customer service. The latter are better placed to protect supply continuity, defend margins, and retain customer trust.

How can we help you? Let’s start talking: https://chemquest.com/lets-start-talking/